210P - Dedicated breast PET for predicting residual disease after breast cancer neoadjuvant chemotherapy

Date 11 September 2017
Event ESMO 2017 Congress
Session Poster display session
Topics Breast Cancer
Staging procedures (clinical staging)
Basic Principles in the Management and Treatment (of cancer)
Presenter Shinsuke Sasada
Citation Annals of Oncology (2017) 28 (suppl_5): v43-v67. 10.1093/annonc/mdx362
Authors S. Sasada1, T. Kadoya2, N. Goga1, A. Emi1, K. Kajitani1, N. Masumoto1, R. Haruta3, T. Kataoka3, M. Okada1
  • 1Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 734-8551 - Hiroshima/JP
  • 2Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima/JP
  • 3Breast Surgery, Hiroshima University Hospital, 734-8551 - Hiroshima/JP



Diagnostic methods to evaluate the response to breast cancer neoadjuvant chemotherapy (NAC) have been established. Dedicated breast PET (DbPET) is a high-resolution molecular breast imaging method, and we investigated the ability of DbPET to predict the presence of residual primary tumors after NAC, compared with whole-body PET (WBPET).


Forty-five patients (47 tumors) underwent WBPET and ring-type DbPET after NAC, and tumors were completely resected between January 2016 and March 2017. The pathological response was classified as complete remission (ypT0), residual intraductal disease (ypTis), or residual invasive disease (ypT≥1). Standardized uptake value (SUV) and tumor-to-normal tissue ratio (TNR) were assessed.


Twelve patients achieved ypT0 and 5 developed ypTis. DbPET detected all cases of ypTis, and WBPET detected only one case of ypTis. The sensitivity, specificity, and accuracy of WBPET for ypT≥is were 54.3%, 83.3%, and 61.7%, respectively, and those of DbPET were 77.1%, 83.3%, and 78.7%, respectively. In the ypT0/ypTis/ypT≥1 groups, the median WBPET-SUV, DbPET-SUV, and DbPET-TNR were 1.0/0.9/1.1, 1.7/1.8/2.2, and 1.0/1.6/1.7 (P = .134, .077, and .008), respectively (Table). Area under the curves of WBPET-SUV, DbPET-SUV, and DbPET-TNR for predicting ypT≥is were 0.610, 0.648, and 0.807, respectively.Table:

210P Comparison of predicting indexes for predicting pathological response

Pathological response WBPET-SUVDbPET-SUVDbPET-TNR
Median (IQR)p Median (IQR)p Median (IQR)p
ypT≥11.1 (0.9-1.7).1342.2 (1.5-3.9).0771.7 (1.1-2.9).008
ypTis0.9 (0.9-1.2)1.8 (1.4-1.9)1.6 (1.4-1.8)
ypT01.0 (0.9-1.0)1.7 (1.5-2.1)1.0 (0.9-1.1)


DbPET was superior to detect residual primary tumors, especially noninvasive carcinoma, after NAC than WBPET. TNR was expected as the better parameter of pathological evaluation than SUV.

Clinical trial identification

Legal entity responsible for the study





All authors have declared no conflicts of interest.